Showing results (1151-1160 of 4,702) with videos related to
Sort By:
Pageof 471
Seminars in Oncology|August 10, 2026
A bibliometric analysis of research evolution on peritoneal metastasis in colorectal cancer (2000-2026): advances in molecular mechanisms and therapeutic strategiesShirui Lu, Xiaolu Du, Hongliang Luo, et al.Seminars in Oncology|August 20, 2026
Silver nanoparticles in tumor microenvironment modulation: Mechanistic insights, preclinical evidence, and translational challengesAlexey Yumashev, Rizaev Jasur, Muazzamov Baxodir, et al.Seminars in Oncology|August 20, 2026
Uncovering an uncommon diagnosis: Encapsulated papillary carcinoma of the male breast in a Jordanian patient-A case reportAbdulsalam Alahmed, Mohammad Al-Hanaktah, Ehab Alroud, et al.Seminars in Oncology|September 6, 2026
Spatiotemporal decoding of the pre-metastatic niche: Multi-omics innovations and clinical horizonsMamdouh A Ragab, Mahmoud A SeliemSeminars in Oncology|September 3, 2026
Integrating patient-reported outcomes into explainable machine learning models for long-term survival prediction in TKI-treated metastatic renal cell carcinomaMiguel Ángel Gómez-Luque, Guillermo Lendínez-Cano, Belén Carrero-García, et al.Seminars in Oncology|September 19, 2026
NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumorZi-Xuan Gou, Yu-Tong Bao, Li-Hong Liu, et al.Seminars in Oncology|September 19, 2026
Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case studyChristina Blagojevic, Richard B Kim, David N Juurlink, et al.Seminars in Oncology|March 1, 1986
Prednimustine v cyclophosphamide-vincristine-prednisolone in the treatment of non-Hodgkin's lymphoma with favorable histopathology: results of a national cancer care program in SwedenE Cavallin-Ståhl, T R MöllerSeminars in Oncology|March 1, 1986
Combined cytotoxic and endocrine treatment of postmenopausal patients with advanced breast cancer: preliminary results of a phase II study of the combination of prednimustine, novantrone, methotrexate, 5-fluorouracil, and tamoxifenH T Mouridsen, M Andersson, L PedersenSeminars in Oncology|March 1, 1985
Clinical implications of recent developments in gastric cancer pathology and epidemiologyP CorreaPageof 471